Characterization of putrescine and cadaverine export in mammalian cells. A pharmacological approach.
We characterized the mechanism(s) involved in the efflux of putrescine/cadaverine from cultured mammalian cells using various pharmacological agents. Verapamil and quinine inhibited putrescine and cadaverine export in monocytic-leukemic RAW 264 and H35 hepatoma cells in a concentration-dependent manner with an IC50 in the micromolar range. Verapamil, which inhibits L-type calcium channels, inhibited putrescine export, regardless of whether calcium was present in the extracellular medium or not. Furthermore, the export of putrescine in the absence of verapamil did not appear to depend upon extracellular calcium. Neither intracellular calcium, external sodium, changes in intracellular pH nor phosphorylation affected the levels of putrescine export independently from changes in intracellular putrescine levels. The data suggest that verapamil and quinine inhibit putrescine/cadaverine efflux from the cell by binding directly to an integral membrane protein.
Tjandrawinata
R R
RR
Department of Biochemistry, University of California-Riverside 92521.
Hawel
L
L
Byus
C V
CV
D000818:Animals; D002103:Cadaverine / Q000378:metabolism*; D002118:Calcium / Q000032:analysis / Q000494:pharmacology; D002460:Cell Line / Q000187:drug effects; D003470:Culture Media / Q000737:chemistry; D051379:Mice; D010766:Phosphorylation; D047428:Protein Kinase Inhibitors; D011700:Putrescine / Q000378:metabolism*; D011803:Quinine / Q000494:pharmacology*; D051381:Rats; D012964:Sodium / Q000032:analysis; D014700:Verapamil / Q000494:pharmacology*
D003470:Culture Media; D047428:Protein Kinase Inhibitors; D012964:Sodium; D011803:Quinine; D014700:Verapamil; D002103:Cadaverine; D002118:Calcium; D011700:Putrescine